InnoCare Pharma Limited (9969.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 19.47B |
| Enterprise Value | 14B |
| P/E Ratio | 22.26 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 6.27 |
| Price/Book Ratio | 2.66 |
| Enterprise/Revenue | 4.78 |
| Enterprise/EBITDA | 15.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.33 |
| Operating Margin | 0.26 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 2.3B |
| Revenue/Share | 1.56 |
| Gross Profit | 2.01B |
| EBITDA | 555.89M |
| Net Income | 625.84M |
| Diluted EPS | 0.36 |
Balance Sheet
| Total Cash | 8.37B |
| Total Cash/Share | 4.74 |
| Total Debt | 2.23B |
| Total Debt/Equity | 0.29 |
| Current Ratio | 4.21 |
| Book Value Per Share | 4.53 |
Price History
| 52-Week Change | -19.5 |
| 52-Week High | 20.18 |
| 52-Week Low | 9.65 |
| Moving Average 50 Days | 14.25 |
| Moving Average 200 Days | 13.12 |
Statistics
| Average Volume | 8.88M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
